Cardiol Therapeutics is Pharmaceuticals in Canada that focus on Cardiol Therapeutics Inc business. Founded in 2017. They cover business area such as Cardiol Therapeutics Inc, therapy, inflammatory heart disease, CardiolRx, hospitalize patient, a prior history, risk factor, cardiovascular disease, clearance, its investigational new drug application, acute myocarditis, sudden cardiac death, people, age.
2017
( 9 years old in 2026 )
Cardiol Therapeutics Inc
-
2265 Upper Middle Road East
Suite 602
Oakville, Ontario L6H 0G5
Canada
Private
Cardiol Therapeutics Inctherapyinflammatory heart diseaseCardiolRxhospitalize patienta prior historyrisk factorcardiovascular diseaseclearanceits investigational new drug applicationacute myocarditissudden cardiac deathpeopleage
* We use standard office opening hours in near Cardiol Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cardiol Therapeutics is Pharmaceuticals business from Canada that founded in 2017 (9 years old in 2026), Cardiol Therapeutics business is focusing on Cardiol Therapeutics Inc.
Cardiol Therapeutics headquarter office and corporate office address is located in 2265 Upper Middle Road East Suite 602 Oakville, Ontario L6H 0G5 Canada.
Cardiol Therapeutics was founded in Canada.
In 2026, Cardiol Therapeutics is currently focus on Cardiol Therapeutics Inc sector.
Above is snippet of Google Trends for "Cardiol Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cardiol Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
